First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1: results from a multicenter open-label phase 2 trial

著录项

• 期刊名称 Journal for Immunotherapy of Cancer
• 作者

  Huijie Duan; Shanyong Yi; Xinfeng Yang; Shegan Gao; Jia Fan; Yalun Li; Yueyin Pan; Yongzhong Luo; Tianshu Liu; Caigang Liu; Ying Cheng; Caicun Zhou; Sheng Hu; Xicheng Wang; Ying Liu; Shanzhi Gu; Shuni Wang; Bao-Hui Han; Jifeng Feng; Jun Zhao; Yufeng Cheng; Shengxiang Ren;

  展开▼
• 作者单位

  展开▼
• 年(卷),期 2024(12),2
• 年度 2024
• 页码 e007227
• 总页数 12
• 原文格式 PDF
• 正文语种
• 中图分类 肿瘤学;
• 关键词